NFKB1 and congenital rubella syndrome: Herein, we reported the activity of a progestogen 17-OHPC in inhibiting CRS, one of the leading causes of severity and mortality associated with COVID-19.17-OHPC inhibited cytokine production both in vivo and in vitro, such pharmacological activity is potentially attributed to its suppression of NF-κB activation in immune cells.